BTK inhibitors

Ibr 140 Pill - yellow round, 9mm

Generic Name: ibrutinib

Pill with imprint ibr 140 is Yellow, Round and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics, Inc.

Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma; Waldenström Macroglobulinemia; Lymphoma; Mantle Cell Lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imbruvica (Ibrutinib)-ibr 140-140 mg-Yellow-Round

Imbruvica
Generic Name: ibrutinib
Imprint: ibr 140
Strength: 140 mg
Color: Yellow
Size: 9.00 mm
Shape: Round
Availability: Prescription only
Drug Class: BTK inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 57962-0014
Inactive Ingredients:
Latest News
Related Drugs